Goldman Says Cephid (CPHD) is 'Oversold'; Likes New Products, L-T Growth Outlook
Tweet
Share
E-mailGet Alerts CPHD Hot Sheet
Price: $52.95 --0%
Rating Summary:
11 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
11 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Cephid (Nasdaq: CPHD) might get a boost this afternoon following comments from Goldman Sachs.
The firm said shares are "oversold" and investors were likely discouraged by fiscal 2013 operating margin forecast.
However, following Cephid's Analyst Day today, Goldman sees a "healthy" long-term growth story on solid new product announcements and long-term revenue guidance.
Goldman sees Cephid remaining the leader in the rapid MDx market.
Shares are down 8 percent on the session following preliminary third-quarter numbers issued Wednesday night.
The firm said shares are "oversold" and investors were likely discouraged by fiscal 2013 operating margin forecast.
However, following Cephid's Analyst Day today, Goldman sees a "healthy" long-term growth story on solid new product announcements and long-term revenue guidance.
Goldman sees Cephid remaining the leader in the rapid MDx market.
Shares are down 8 percent on the session following preliminary third-quarter numbers issued Wednesday night.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Rockwell Automation (ROK) PT Lowered to $490 at DA Davidson
- Cummins (CMI) PT Lowered to $675 at Jefferies
Create E-mail Alert Related Categories
Analyst Comments, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
